A TREAT TO TARGET APPROACH DECREASES THE RATE OF CD-RELATED ADVERSE OUTCOMES VERSUS A CLINICAL APPROACH IN PATIENTS WITH MODERATE TO SEVERELY ACTIVE CROHN'S DISEASE: DATA FROM CALM

Jean-Frederic Colombel  1     Remo Panaccione  2     Peter Bossuyt  3     Filip Baert  4     T. Vanásek  5     Ahmet Danalıoğlu  6     Gottfried Novacek  7     Alessandro Armuzzi     Xavier Hebuterne     Simon Travis     Silvio Danese     Walter Reinisch     William Sandborn     Paul Rutgeerts     Daniel W. Hommes     Stefan Schreiber     Ezequiel Neimark     Bidan Huang     Qian Zhou     Wan J Le    
1 Icahn School of Medicine at Mount Sinai,New York,United States of America
2 University of Calgary,Calgary,Canada
3 Imelda General Hospital,Bonheiden,Belgium
4 AZ Delta,Roeselare,Belgium
5 Hepato-Gastroenterologie HK, s.r.o.,Hradec Králové,Czech Republic
6 Bezmialem Vakif University School Of Medicine,Gastroenterology,İstanbul,Turkey
7 Medi

Conference
25th UEG Week 2017

Citation
United European Gastroenterology Journal 2017; 5 (Supplement 1)


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Forgot your password?

Reset myUEG password

Social Sharing